Abstract:The type II-A CRISPR effector SpCas9 has gained widespread popularity as an efficient and programmable genome editing tool. However, much remains to be known about novel compact variants that may overcome some limitations of current systems . Recently, alternative CRISPR-Cas systems with highly compact nucleases capable of genome editing in mammalian cells have been discovered through metagenomic analysis of uncultivated microbes, including Cas9d (a type II-D CRISPR-Cas effector) . Here, we report the cryo-EM structures of a Cas9d nuclease (747 amino acids in length) in multiple functional states, revealing a stepwise process of DNA targeting involving a conformational switch in a REC2 domain insertion. Our structures provide insights into the intricately folded guide RNA which acts as a structural scaffold to anchor small, flexible protein domains and facilitate DNA target recognition. We find that the sgRNA can be truncated by up to ∼25% yet still retain activity . We also show that despite preferentially targeting an NGG PAM, Cas9d exhibits a unique mechanism for PAM recognition. Finally, we identify the first Cas9d smaller than 800 amino acids exhibiting robust nuclease activity in mammalian cells. Using ancestral sequence reconstruction, we demonstrate that it is possible to generate compact nucleases capable of efficient genome editing by expanding the diversity of Cas9d families. Collectively, our results provide mechanistic insights into the evolution and DNA targeting of diverse type II CRISPR-Cas systems, providing a molecular blueprint for future rational re-engineering of minimal RNA-guided DNA nucleases.

Structural basis for the activation of a compact CRISPR-Cas13 nuclease

Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d

Rational Design of Mini-Cas9 for Transcriptional Activation

Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3

Molecular mechanism for target RNA recognition and cleavage of Cas13h

Structure of the miniature type V-F CRISPR-Cas effector enzyme

Structure and function of a bacterial type III-E CRISPR–Cas7-11 complex

DNA targeting by compact Cas9d and its resurrected ancestor

Engineered CRISPR RNA improves the RNA cleavage efficiency of hfCas13X

A strategy for Cas13 miniaturization based on the structure and AlphaFold

Structural basis for the activity of the type VII CRISPR-Cas system

Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage

CRISPR-RNA binding drives structural ordering that primes Cas7-11 for target cleavage

Structure‐guided Engineering of Thermodynamically Enhanced SaCas9 for Improved Gene Suppression

Large-scale structural rearrangements unleash indiscriminate nuclease activity of CRISPR-Cas12a2

Molecular Basis and Engineering of Miniature Cas12f with C-rich PAM Specificity

Conformational Activation Promotes CRISPR-Cas12a Catalysis and Resetting of the Endonuclease Activity

RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2

Cryo-EM structure and protease activity of the type III-E CRISPR-Cas effector

R-loop formation and conformational activation mechanisms of Cas9

CRISPR-Cas9 Structures and Mechanisms.